Ignite Creation Date:
2025-12-24 @ 1:27 PM
Ignite Modification Date:
2026-04-18 @ 5:02 AM
Study NCT ID:
NCT05388695
Status:
RECRUITING
Last Update Posted:
2025-06-18
First Post:
2022-05-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors
Sponsor:
Hebei Senlang Biotechnology Inc., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
19+22 for B-ALL/NHL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |